Effects Of Type 2 Diabetes On Multiple Metabolic Disorders And Cardiovascular Metabolic Disease

Background:Observational studies have shown inconsistent results of associations between Type 2 Diabetes(T2DM)and blood lipid profiles,whereas evidence from randomized control trials(RCTs)were lacking.Objectives:Our study aimed to investigate the causal effect of T2DM on blood lipid profiles using two-sample Mendelian Randomisation(MR).Methods:We obtained genetic variants for T2DM and blood lipid profiles including high-density lipoprotein(HDL),low-density lipoprotein(LDL),triglycerides(TG)and total cholesterol(TC)from international genome-wide association study(GWAS)through several public databases.Two-sample MR method was applied to explore the possible causal effect of T2DM on blood lipid profiles per database and results were further meta-analyzed.Results:Genetically predicted 1-unit higher log odds of T2DM had causal effect on TG(estimated effect β coefficient:0.03,95%confidence interval[CI]:0.00 to 0.06)and HDL(estimated effect β coefficient:-0.08,95%CI:-0.12 to-0.06).Causality of T2DM on TC and LDL were not found(β:-0.01,95%CI:-0.02 to 0.01 for TC and β:0.01,95%CI:-0.01 to 0.02 for LDL).For different size of lipoprotein particles,one unit higher of log odds of T2DM was associated with higher small LDL(β:0.04,95%CI:0.00 to 0.08,p=0.048),and lower HDL except for small particles(β ranged between-0.09 to0.04)Conclusions:Evidence of our present study was supportive for causal effects of T2DM on HDL and TG levels and various sizes of lipoprotein particles as well which may be helpful in early diagnosis of multiple metabolic disorders secondary to T2DM and indicating new treatment targets.ObjectivesTo investigate the roles of cardiometabolic factors(including blood pressure,blood lipids,thyroid function,body mass,and insulin sensitivity)in mediating the causal effect of type 2 diabetes(T2DM)on cardiovascular disease(CVD)outcomes.Design Two-step,two-sample multivariable Mendelian randomization(MVMR)study.SettingInternational genome-wide association study(GWAS)consortia data.ExposureT2DM,blood pressure:systolic blood pressure(SBP),diastolic blood pressure(DBP);blood lipids:low-density lipoprotein(LDL),high-density lipoprotein(HDL),total cholesterol(TC),triglycerides(TG);thyroid function:hyperthyroidism,hypothyroidism;body mass index(BMI),waist-hip-ratio(WHR),and insulin sensitivity.Main outcomesCVD including coronary heart disease(CHD),myocardial infarction(MI)and stroke.MethodsSummary-level data for exposures and main outcomes were extracted from GWAS consortia.We used two-sample MR to illustrate the causal effect of T2DM on CVD subtypes and regression-based MVMR to quantify the possible mediation effects of cardiometabolic factors on CVD.ResultsEach additional unit of log odds of T2DM increased 16%risk of CHD[OR:1.16,95%confidence interval(CI):1.12-1.21],15%risk of MI(OR:1.15,95%CI:1.101.20),and 10%risk of stroke(OR:1.10,95%CI:1.06-1.13).In mediation analysis,SBP,DBP and TG were found as main mediators,while the mediation effects of other cardiometabolic factors were not significant.The proportion of total effect of T2DM on CHD mediated by SBP,DBP and TG was 16%(95%CI:8%-24%),7%(95%CI:1%-13%)and 10%(95%CI:2%-18%),respectively.Mediation effect of SBP and DBP on MI and stroke,TG on MI was also prominent,while mediation effect of TG on stroke was not significant.Combined mediation effect of all three mediators accounted for 29%,26%and 13%of total effect of T2DM on CHD,MI and stroke,respectively.ConclusionSBP,DBP and TG mediate a substantial proportion of the causal effect of T2DM on CVD and thus interventions on these factors might reduce considerable excess risk of CVD among T2DM patients.